TecMed has entered into an agreement to acquire the Ypsomed Diabetes Care business of SIX-listed Ypsomed for up to CHF420m (US$517m), including earn-out. TecMed is a Burgdorf-based company controlled by…
Switzerland: Ypsomed to sell diabetes business to TecMed for up to CHF420m
…
…






